|
|
||||||||
INNOVATIVE METHODOLOGY
1Cummings School of Veterinary Medicine at Tufts University, North Grafton; and 2Brigham and Woman's Hospital, Boston, Massachusetts
Submitted 23 April 2006 ; accepted in final form 2 July 2006
| ABSTRACT |
|---|
|
|
|---|
murine; specific airway resistance; bronchial reactivity; forced oscillation technique; methacholine
We investigated the use of restrained whole body plethysmography (RWBP), an adaptation of the original method of body plethysmography (pressure plethysmography) in humans (15) that was later used in guinea pigs (3). Mice are fast breathers (36 Hz), so special considerations concerning plethysmographic design and validation were addressed. The intent of this study was to provide an initial proof of concept for RWBP in conscious mice and thus stimulate future applications and comparisons with alternative systems. We hypothesized that 1) baseline sRaw-RWBP and associated MCh responses would be similarly reproducible to Raw-forced oscillation technique (FOT), 2) values for sRaw measured with RWBP (sRaw-RWBP) would be comparable to sRaw derived from a combination of Raw from the FOT (Raw-FOT) and Boyles law plethysmography to obtain functional residual capacity (FRC), or DCP to obtain an alternative conscious sRaw (sRaw-DCP), 3) strain-specific airway responsiveness would be accurately characterized by RWBP, and lastly, 4) RWBP could be used to characterize longitudinally the increase in airway responsiveness associated with chronic (10 wk) allergen challenge in a single group of BALB/c mice.
| METHODS |
|---|
|
|
|---|
Animals. Pathogen-free female C57BL/6 (n = 18) (Charles River Laboratories, Wilmington, MA), A/J (n = 18), and BALB/c (n = 59) (Jackson Laboratories, Bar Harbor, MA), purchased at 810 wk of age (1922 g), were used for this experiment. Each mouse was individually identified; they were housed in cages in groups of four to five in an Association for Assessment and Accreditation of Laboratory Animal Care accredited facility that provided only HEPA filtered air. Food and water free of ovalbumin (OVA) were provided ad libitum. A sentinel program ruled out the presence of any of the following infectious agents in the housing area of the mice during the study: parvoviruses (mouse parvovirus-1, mouse parvovirus-2, microvillus membrane, nonstructural protein-1), Sendai virus, pneumonia virus of mice, mouse hepatitis virus, Theiler's murine encephalitis virus, reovirus, Mycoplasma pulmonis, and mouse rotavirus (epizootic diarrhea of infant mice).
Study design. In A/J, C57, and BALB/c mice, the responses to MCh aerosol were measured using RWBP and the FOT. In BALB/c mice, we additionally used DCP. Finally, we measured MCh responses in the BALB/c mice after allergen sensitization (intraperitoneal) and aerosol challenges.
Physical properties of the RWBP. The custom-built whole body pressure plethysmograph (RWBP) consisted of clear Lucite outer chamber walls (5.8 cm height x 7.7 cm width x 20.2 cm length = 902 ml, thickness 12 mm). The outer chamber held an inner restraint chamber (e.g., nose cone restrainer, Kent Scientific, Torrington, CT) (Fig. 1). The restraint chamber was modified by drilling several holes (23 mm) into the wall, overlying the region where the thorax and abdomen of the mice lie.
|
3.2 s to 36% peak pressure) was created by a Luer connector mounted in the wall of the box, which was attached to a length of tubing, a stopcock, and needle (22 g, 2 cm). The leak resistance was measured to be 5.37 cmH2O·ml1·s and inertance 0.029 s2/ml. A step pressure created by 1) hammering gently the plunger of a syringe loaded to an expected volume (0.02 ml), and 2) balloon burst both peaked between 19 and 21 ms, with a thermal time constant (described by a single compartment) of 0.95 s. Amplitude of box volume (Vbox) was examined as a function of input frequency using digitally controlled square and sinusoidal flows delivered with a piston-driven mouse ventilator (flexiVent, Scireq, Montreal, Canada). Vbox amplitude remained within 3% of the delivered volume (0.1 ml) from 1 to 10 Hz, and within 0.075% between 2 and 5 Hz, the range most relevant to breathing in conscious mice. Therefore, the conditions were adiabatic across these frequencies. Time shifts between flow, delivered via the pneumotachograph within the box, and peak box pressure averaged <3 ms (range 16 ms) from 0.519.5 Hz generated using a broadband input generator (flexiVent, Scireq). Pressure in the plethysmographic chamber was sampled using a low-range (±10 cmH2O) differential pressure transducer (TRD 5700, Buxco Electronics, Wilmington, NC) referenced to a chamber open to atmosphere (
= 6 s). A pneumotachograph (8431 series, Hans Rudolph, Kansas City, MO) with dead space of 0.3 ml, heated to 3839°C, was custom fitted via O-ring assembly to the proximal port of the nose cone for measurement of flow and flow-derived parameters. Data were sampled at 2,500 Hz per channel using commercial hardware (Max1420 Buxco Electronics, PCI 6024E, National Instruments) and software (Biosystem XA version 2.7.4, Buxco Electronics). The pneumotachograph was calibrated by integration of the flow, injected as a known volume (0.5 ml). Vbox derived from box pressure was calibrated by rapid injection of a known volume (0.1 ml) into the chamber, between each mouse experiment, and checked repeatedly using injections of varying volumes and quasi-sinusoidal inputs. Bias flow (0.5 l/min) was employed between recordings, and the box vented fully between MCh challenges. Measurement of sRaw using RWBP. For measurements using RWBP, mice were loaded into the restrainer from the rear and using the mobile back plate, were pushed forward until their heads were straight and muzzles in contact with the inner wall of a rubber O-ring (i.e., "cuff") that was used to prevent leak.
The amount of leak around the muzzle was investigated in a pilot study involving BALB/c female mice (n = 11, 2026 gm). A steady airflow (30 ml/s) was delivered simultaneously via Y piece to (1) the mouse assembly (i.e., pneumotachograph, nose cone, and mouse), and (2) a parallel "shunt" pathway opened to atmosphere. Flow through the shunt pathway was measured using a separate calibrated pneumotachograph. After total flow was measured through the shunt pathway, the other pathway was attached to the mouse assembly. The proportion of flow lost to the mouse pathway was considered the percent leak.
The mean (±SD) reduction in shunt flow was 0.93 ± 0.97% (range 0 to 2.6%), indicating that the flow resistance through the cuff area was on average >100 times greater than the shunt pathway. Thus the leak in the cuff contributed to <1% error in the measurement of flow or sRaw.
The Vbox-flow (x-y) plots were constructed post hoc from the primary signals using commercial software (Acknowledge v. 3.7.3, Goleta, CA). Primary waveforms (Vbox, flow) were reviewed and the time-period indicative of peak responses to MCh was identified by repeated sampling. Peak responses to MCh were found in pilot studies to occur between 1.5 and 2.5 min after the initiation of exposure to MCh. The slope (
) of the Vbox-flow plot was measured manually using a protractor (accurate to 0.5°) on the straightest possible segment between 1 to 1 ml/s (i.e., the left side of the loop). Examples of a complete bronchoprovocation and the derivation of sRaw (sRaw-RWBP) from primary signals are shown in Fig. 2A. The straight segment corresponded to the rapid (1012 ms) transition from expiration to inspiration where volume shift was negligible. This technique has been shown to minimize the contribution of heating and humidification to the box pressure (3, 4), and sRaw derived from this period was equivalent in panting and nonpanting human subjects (35). Gains were set to produce angles (tangents) between 40 and 75°. Breaths with evidence of laryngeal braking were avoided (56). sRaw-RWBP was computed from the tangents as follows:
![]() |
|
|
E) (20) employed for measurements. Once the mouse was secured within the thoracic chamber with the head protruding through an appropriate neck seal, the nasal chamber was attached, and bias flow (0.5 l/min) initiated. For measurements, the bias flow was turned off temporarily to maximize signal to noise. Computation of sRaw measured with DCP (herein "sRaw-DCP") followed protocols established by Pennock et al. (42) and later applied to mice by Flandre et al. (20), whereby the time lag (dT) between the thoracic and nasal flow at zero crossing (during transition between inspiration and expiration) was utilized as follows:
![]() |
Measurement of respiratory system impedance using the FOT. Methods for the FOT, including calibration techniques, followed previous publications (25, 54). Briefly, mice were anesthetized with ketamine (5075 mg/kg) and xylazine (5 mg/kg) (Butler, Dublin, OH) intraperitoneally, and a tracheostomy was performed with a 19-g cannula (Becton Dickinson, Franklin Lakes, NY). Once anesthesia was confirmed by lack of response to toe pinch, mice were paralyzed with pancuronium (1 mg/ml, Baxter Healthcare, Irvine, CA). Supplemental ketamine (25 mg/kg ip) was provided every 0.5 h. Ventilation was set at frequency of 200 breaths/min, tidal volume (VT) 0.3 ml, positive end-expiratory pressure 3.0 cmH2O, and inspired oxygen was supplemented at all times. Repeated measurements were performed using a commercial data acquisition system for input impedance between 0.5 and 19.5 Hz (Quick Prime 3 analyzer, FlexiVent System, SCIREQ, Montreal, Quebec). A constant-phase model (25) was employed to compute Raw ("Raw-FOT"), in addition to tissue resistance (Gti) and elastance (Hti) coefficients. Baseline Raw, Gti, and Hti were tabulated, but the MCh responses using Gti and Hti were not used for comparisons with conscious measurements; only Raw was used for this purpose. To derive a value of sRaw (i.e., Raw x FRC) from FOT for comparison with conscious sRaw-RWBP, we measured FRC using the Boyles law method in a separate group of similarly anesthetized-tracheostomized female C57 mice (n = 30, 1922 g) using a commercial plethysmograph (PLY 3111, Buxco Electronics), data acquisition system (XA Biosystem 2.7.4, Buxco Electronics), and standard calibration routines.
Reproducibility of baseline (unprovoked) measurements. A subset of C57BL/6 mice (n = 12) used for RWBP and FOT were initially used to examine reproducibility (within animal, within group) of sRaw-RWBP. Several recordings were made over 45 min, on a separate day in the AM and PM (10 min each), and on a third day for 10 min. For each time point, an average of 10 breaths selected at random was used for analysis. The results were expressed as CV and 95% confidence intervals (see Statistical analyses). The within-group CV was also compared between strains of mice.
MCh challenges in conscious mice.
Challenges were conducted at the same time of day (morning or afternoon) for each mouse. Ambient temperatures in the laboratory ranged 2123°C and humidity 2545%. Baseline recordings were obtained after 2 min acclimation to the chamber. For aerosol exposures, the mice within their restraint chambers were detached from the pneumotachograph and attached to an adjacent enclosure setup for nose-only exposures. For RWBP, aerosols were generated with an ultrasonic nebulizer (Aerogen, Aeroneb, Dangan, Galway, UK), and directed through the T piece using a low-flow (470 ml/min) regulator, thus permitting the mice to breath a standardized aerosol concentration (reported mass median diameter = 3.1 µm). Following each exposure, mice were returned within 20 s to the RWBP, and the recording of data resumed for 5 min. For DCP, aerosols were delivered from the Aerogen nebulizer directed via stopcock into the nasal chamber. Bias flow caused the aerosol to traverse the nasal chamber at the level of the nares, assuring exposure to the aerosol. Doses of MCh were chosen that induced, on average, an increase in sRaw-RWBP to 300% baseline. Specifically, MCh (Provocholine, Methapharm, Brantford, Ontario) was nebulized for 60 s to C57 at concentrations of 0 (i.e., saline), 10, 50, and 100 mg/ml, in A/J mice at 0, 1, 5, and 10 mg/ml, and in BALB/c mice at 0, 6.25, 12.5, and 25 mg/ml (pre- and post-OVA exposure). During the comparison of mouse strains (A/J, C57, and BALB/c) using RWBP, the above doses were delivered without stopping criteria. However, during the comparison of techniques (RWBP, DCP, and FOT) and following allergen challenge in BALB/c mice, we stopped MCh challenge when EF50 to
1 ml/s, since these mice were expected to become more responsive over time, and it was therefore deemed unsafe to give all doses of MCh. The provocative concentration that caused sRaw to increase to >175% postsaline value was computed by log-linear interpolation across the final two concentrations of MCh employed for each mouse, according to Sterk et al. (51). The provocative concentration of MCh that increased sRaw to 175% postsaline values (ED175) was used as an index of airway responsiveness.
MCh challenges using the FOT. Aerosols were delivered directly into the tracheal cannula during lung inflation during mechanical ventilation (flexiVent, Scireq, Montreal, Quebec). Ten-second nebulization periods were used, followed immediately by a series (815) of measurements. The lung was inflated to total lung capacity (30 cmH2O airway pressure) once after each aerosol delivery. Forced oscillations during apnea (3 s in duration) were applied every 17 s for 5 min. Dosage ranges were predetermined in pilot studies to evoke between 10 and >75% increase in Raw. MCh in C57 mice was delivered at 0 (saline), 4, 8, and 16 mg/ml, and in AJ we used 0, 2, 4, and 8 mg/ml. The concentration of MCh that provoked an increase in Raw-FOT to 175% baseline (ED175) was determined by log-linear interpolation as described above.
Allergen sensitization and aerosol exposure of BALB/c mice. A subset of the BALB/c mice (n = 9) were immunized and sensitized to OVA using a procedure modified from past studies (10, 36, 37, 53). Briefly, mice received an intraperitoneal injection of 50-µg OVA (grade V, 98% pure, Sigma Aldrich, St. Louis, MO) precipitated in aluminum hydroxide and magnesium hydroxide (Imject Alum, Pierce, Rockford, IL) 14 and 7 days before inhalational exposure. Mice were then exposed to 2.5% aerosolized OVA for 30 min, three times a week for a total of 10 wk, and on the 5th and 10th wk, MCh challenges were performed 48 h after OVA exposure. Inhalation exposures were performed using a custom-built whole body exposure system during which air was drawn through a 0.4 m3 chamber at a flow rate of 80 l/min. The OVA solution was delivered into the chamber using a Pari LC JET fine-particle nebulizer (Pari, Paris, France), delivering particles with reported mean median diameter of 1.6 µm, and compressor (model NE-CO8, Omron Healthcare, Vernon Hills, IL). The mass concentration of the particles within the breathing zone of the mice was continuously monitored using a laser photometer (SidePak, AM510, TSI, Shoreview, MN). Flow from the compressor was regularly adjusted throughout the exposure period to keep the OVA concentration between 15 and 20 mg/m3.
Statistical analyses. The intra-animal and within-group reproducibility of noninvasive sRaw vs. invasive Raw were expressed as CV and 95% confidence limits, and time effects were tested using repeated-measures ANOVA. The MCh responses were analyzed using repeated-measures ANOVA. The effect of mouse strains on sRaw-RWBP, sRaw-DCP, Raw-FOT, or indexes of airway reactivity (ED175) was analyzed using ANOVA. Pairwise comparison between strains was performed using Student's t-tests. Paired tests were employed to test the effect of allergen on ED175 in BALB/c mice. Significance was attributed to data when P < 0.05. All values are expressed as means ± SE, except where indicated.
| RESULTS |
|---|
|
|
|---|
|
Strain-specific airway responsiveness. Measurement of sRaw-RWBP took between 3 and 6 min, including loading, and MCh challenges took between 16 and 30 min, depending on airway responsiveness. Baseline sRaw-RWBP was significantly lower (P < 0.001) in C57 compared with AJ or BALB/c (Table 3). Baseline Raw-FOT was not different between AJ (0.35 ± 0.12 cm·ml1·s), C57 (0.35 ± 0.16 cm·ml1·s), and BALB/c (0.30 ± 0.06 cm·ml1·s) mice. The mean ± SE FRC determined in a separate group of C57 mice was 0.265 ± 0.009 ml. These values were used to construct sRaw-FOT. MCh caused a significant dose-dependent increase in sRaw-RWBP (Fig. 3A). Accompanying the change in sRaw-RWBP was a significant decrease in respiratory frequency but no significant change in VT for any strain of mice (Fig. 3, B and C). MCh caused a dose-dependent increase in Raw in all three strains of mice (Fig. 4). Airway responsiveness was significantly different between AJ, C57, and BALB/c mice for sRaw-RWBP, and the descending order of reactivity was AJ > BALB/c > C57 (Table 4). Using Raw-FOT, there was no difference between C57 and BALBc ED175, but both strains had a significantly higher ED175 than A/J. Therefore, airway reactivity in descending order by FOT was A/J > BALB/c = C57. A comparison of MCh responses between methods using a single strain of mouse (BALB/c) and standard doses for MCh is shown in Fig. 5. There was no difference in ED175, derived for RWBP, DCP, and FOT. However, the percentage change in sRaw-RWBP or sRaw-DCP was significantly higher than the percent change in Raw-FOT. Baseline sRaw-RWBP (0.63 ± 0.05 cm/s) was significantly lower (P < 0.001) than mean sRaw-DCP (1.82 ± 0.11 cm/s).
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Advantages of RWBP may include the ease of loading, nose-only exposure, direct nonplethysmographic measurement of flow, and the lack of a neck seal that may constrict the airway or impair loading. For use of RWBP, none of the mice required acclimation to complete several sets of baseline measurements and one or more bronchoprovocations, which may be an additional advantage. While we did not specifically measure indexes of stress directly, and therefore it is not possible to comment on their physiological responses to RWBP, the mice were active, grooming, and appeared unharmed each time they were removed from the chamber.
Critique of the plethysmographic device (RWBP). The size of the box (902 ml, or 45 ml/g) was relatively large compared with past studies employing pressure plethysmographs in guinea pigs or mice (49, 56). This contributed to consistent adiabatic conditions, an acceptable feature of pressure plethysmography (32, 49). One problem was frequent drift in the baseline of the pressure signal due to warming of the chamber by reloading of the mouse. This could be avoided in future experiments by conducting the entire study without opening the chamber, i.e., aerosolizing agonists to the mice within the chamber using special delivery systems (3, 19). Incorporation of heating elements or warmed water (39, 40, 42) or decreasing the size or thickness of the chamber walls may also serve to stabilize the thermal conditions of the box interior. Alternatively, flow-type plethysmography has been described (49), which would minimize the effects of baseline thermal drift, although pose additional challenges, e.g., maintaining calibration. A significant challenge in the use of any plethysmograph is to understand the confounding influence of heating and humidification on the box pressure signal. Heating and humidification of inspired gas likely created some looping in the XY plots (31) based on our pilot studies. However, this source of looping appeared not to confound the measurement of sRaw (Table 1). Furthermore, heating of the plethysmograph caused a decrease in box pressure amplitude (i.e., Vbox) by only 10%, suggesting that gas conditioning within the dead space in front of the mouse is significant compared with the absence of conditioned gas as in the unrestrained setting. In sum, there are several improvements that could be made to the current design to improve stability and convenience, but none of these would improve fundamental accuracy of sRaw derived by RWBP.
Reproducibility of sRaw. An understanding of test reproducibility is paramount to the application of any device used to measure pulmonary function. The intra-animal CV for sRaw-RWBP (measurements made every 15 min) in mice (6.6%) was similar to guinea pigs (26) and very similar to Raw-FOT (3.4%) as measured. Similarly, the CV for respiratory system resistance in conscious mice using Ztr was 6% (30), although this was obtained after two previous acclimation periods of measurement, each 2 h apart. The within-group CVs were equivalent for sRaw-RWBP and Raw-FOT in the multiple strains of mice in this study. In sum, sRaw-RWBP was no less reproducible at baseline or after MCh than Raw, despite the fact that the measurement was made without control of several important factors such as VT and PEEP.
Comparison between sRaw-RWBP, sRaw-FOT, and sRaw-DCP. The measurements using FOT and FRC were employed in part to understand the validity of RWBP for measurement of airway mechanics, specifically sRaw. The baseline values for Raw in both C57 and AJ strains were comparable to previously published values (9, 25, 44) and, therefore, served as a reasonable gold standard. The mean value of sRaw-RWBP in C57 (0.51 cm/s) was about five times the value obtained for sRaw-FOT (0.095 cm/s), commensurate with the contribution from the upper airways. In support of this notion, the upper airways contributed to about four-fifths of total Raw in rats (13). The exact contribution of the upper airways to the baseline and postprovocation measurements of sRaw-RWBP were not disclosed by this study but require further study in conscious mice.
An additional approach that was employed to better understand the validity of sRaw-RWBP was the comparison with sRaw-DCP. In BALB/c mice where both techniques were performed, sRaw-RWBP (0.63 ± 0.05 cm/s) was significantly lower than sRaw-DCP in our study (1.82 ± 0.11 cm/s) and lower than past measures of sRaw-DCP in BALB/c mice, i.e., 1.02 (20), 1.18 ± 0.4 (18), and 1.50 cmH2O/s (12). Our values for sRaw-RWBP were also lower than sRaw-DCP in other strains of mice, i.e., 1.2 (20) or 1.44 ± 0.5 cmH2O/s (18) in C57 and 1.68 cm H2O/s in AJ mice (20). The basis for the large discrepancy between sRaw-RWBP and sRaw-DCP was not disclosed by our study. The higher values across the board for sRaw-DCP compared with sRaw-RWBP may relate to differences in the computation methods and the constrictive effect of the neck seal used for DCP. The computation for DCP is based entirely on nasal vs. thoracoabdominal phase lag, which may be influenced by several instrument and host factors previously reviewed by Pennock et al. (42). Another factor that may have confounded our measurements of sRaw-DCP was the tension on the neck seal. The seal must be tight enough to restrain the mouse while avoiding leak, yet loose enough to avoid constriction (20). As it is difficult to standardize the tightness of neck seals, this may introduce some additional variability in the measurements and heighten baseline values.
The use of the restraint system used for RWBP may also confound measurements of sRaw by depressing lung volumes (FRC, total lung capacity). Although the position of the rear plate was adjusted according to the size of the mouse, lung volumes may be reduced in this position. Further study employing imaging (e.g., computed tomography) holds promise to explore the effects of tube restraint.
Strain-specific airway responsiveness.
The C57 mice exhibited significantly higher breathing frequency, minute volume, and peak flows than A/J or BALB/c mice, and higher VT than A/J mice. The C57 strain was previously found to have higher
E than BALB/c (20), and this was thought to reflect their greater basal metabolism, body temperature, and lower hematocrit. Breathing frequency, VT, and
E were slightly higher in this study than several past studies employing DCP (18, 20) than head-out plethysmography (17, 21, 55) or UWBP (48), although Delorme and Moss (12) using DCP and Hamelmann and coworkers (27) using unrestrained plethysmography found similar values for frequency. We speculate that the higher ventilatory rates in this study relate to the presence of excessive dead space (0.3 ml), which cause the mice to compensate appropriately. This did not appear to complicate the process of data collection or cause harm to the mice. However, the presence of hyperpnea may have contributed to differences in MCh delivery or response to MCh due to altered lung volumes.
Airway responsiveness in the three strains of mice differed significantly (Table 3). Concerning our gold standard (FOT), MCh responsiveness paralleled past data on this subject using BALB/c mice (54). The descending order of airway responsiveness differed between RWBP (A/J > BALB/c > C57) and FOT (A/J > BALB/c = C57) largely due to relatively lower responsiveness of conscious C57 mice. The relative airway responsiveness found in this study using RWBP (A/J > BALB/c > C57) mirrored past studies that have employed invasive technologies in two or three of the same strains (11, 16, 52), as well as published data on airway reactivity (using UWBP) from the vendor for C57 and A/J mice (46). One study that compared double-chamber (sRaw) to single-chamber (enhanced pause) measures of airway responsiveness disclosed rank orders BALB/c > A/J > C57 for DCP and A/J > BALB/c > C57 as in our study for UWBP (12). The inability to characterize A/J mice as hyperresponsive, and the poor reproducibility of airway responsiveness indexes (e.g., provocative concentration of MCh that doubled resistance) were cited as major weaknesses of DCP by that study. In another study using UWBP (58), the order was AJ > BALB/c = C57 as seen in our invasive measurements. Hence there are inconsistencies in the literature with regard to the airway responsiveness of BALB/c vs. C57 mice, but most studies show that A/J mice are considerably more responsive to MCh than other strains before any sensitization or exposure to allergen. We do not have an explanation for the differences between conscious and invasive measures of airway responsiveness in our study. It is possible that conscious measurements of airway responsiveness in C57 mice, which are typically hyporesponsive, were influenced by their uniquely exaggerated
E, or another conscious factor that altered drug delivery.
To further compare RWBP to DCP and FOT for measurement of airway responsiveness, we employed all three techniques in a single strain (BALB/c) of mice. Despite different modes of delivery and concentrations of MCh employed to construct a dose-response curve, the three methods produced equivalent ED175. Rather than imply that these methods are equally sensitive, the data would suggest that MCh delivery methods and doses have been adjusted over time by investigators to obtain a dose-response curve in nonsensitized BALB/c mice between 0 and 30 mg/ml. If we had employed the same method of MCh delivery (e.g., intravenous route) for the same time, we might have obtained different results. For example, it would be expected that the delivery of MCh for 60 s into the lower respiratory tract of intubated mice would likely have produced greater responses, and therefore our conclusion concerning airway responsiveness as a function of technique would have been different (i.e., FOT would have detected greater airway responsiveness). Because intravenous responses to MCh are poorer than aerosolized responses, we chose the aerosol route.
Furthermore, it is impossible to determine the contribution of the nose or glottis vs. lower airways in the response to MCh. This could be a significant limitation to these methods during pharmacological testing. The higher percentage responses in the conscious animals (RWBP, DCP) vs. anesthetized intubated mice (FOT) (Fig. 5) may have resulted from upper airway constriction, either by direct stimulation of cholinergic receptors in the nasal mucosa (34, 45) or cholinergic reflexes involving the glottis, nasal cavities, or other structures following lower airway deposition of MCh (13, 14), as observed previously in rats. In one study in rats (14), frequent glottic closure was noted, and this explained the observed marked increase in expiratory Raw with lower airway deposition of MCh. We too noted frequency glottic closures (periods of zero flow at the initiation of expiration), but breaths with glottic closures, while excluded for analysis in this study, could be analyzed on the basis of the tangent immediately after glottic opening. Thus it is tempting to speculate that RWBP permitted a qualitative analysis of the "source" of expiratory resistance and, therefore, exclusion of resistance caused purely by glottic closure. Further studies are warranted to disclose the contribution of the upper airways to the responses measured using RWBP, particularly in mice where there is a paucity of such data.
Allergen responses. The effect of OVA exposure by aerosol in sensitized mice did not evoke a change in baseline sRaw (pre-OVA: 0.711 ± 0.038, 5 wk: 0.66 ± 0.02; 10 wk: 0.785 ± 0.084 cm/s). Similarly, no effect was seen in baseline airway or tissue mechanics in a past study using a similar protocol comparing OVA/OVA to OVA+/OVA+ BALB/c mice (54). Using RWBP, there was a significant decrease in ED175 at 5 and 10 wk, demonstrating that it was feasible to track significant changes in airway responsiveness longitudinally. The site of antigen effects was not established in this study. While OVA challenge in sensitized mice is thought to induce airway hyperresponsiveness primarily due to lower airway inflammation and remodeling, similar responses to antigen have been found in the nasal passages of mice (14, 29). Further studies are warranted to relate structural to functional responses to allergen challenge. However, it is evident from our data that RWBP offers an opportunity to perform longitudinal studies of chronic airway disease.
In conclusion, this study demonstrates for the first time the measurement of sRaw using RWBP in conscious mice. The noninvasive method of RWBP permitted highly reproducible measurements of sRaw, without acclimation to the instrument. Values for sRaw were very similar to those derived from the invasive FOT. Strain-specific and allergen-induced effects on airway reactivity were demonstrated using RWBP. The technique of RWBP holds promise for acute or longitudinal studies of airway disease in conscious mice.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
U. Mabalirajan, J. Aich, A. Agrawal, and B. Ghosh Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-{beta}1 in an extended subacute mouse model of allergic asthma Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L411 - L419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ahmad, U. Mabalirajan, D. A. Joseph, L. Makhija, V. P. Singh, B. Ghosh, and A. Agrawal Exhaled nitric oxide estimation by a simple and efficient noninvasive technique and its utility as a marker of airway inflammation in mice J Appl Physiol, July 1, 2009; 107(1): 295 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mabalirajan, A. K. Dinda, S. Kumar, R. Roshan, P. Gupta, S. K. Sharma, and B. Ghosh Mitochondrial Structural Changes and Dysfunction Are Associated with Experimental Allergic Asthma J. Immunol., September 1, 2008; 181(5): 3540 - 3548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Reynolds, V. J. Johnson, and D. G. Frazer Unrestrained acoustic plethysmograph for measuring specific airway resistance in mice J Appl Physiol, August 1, 2008; 105(2): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. T. Bates, J. Thompson-Figueroa, L. K. A. Lundblad, and C. G. Irvin Unrestrained video-assisted plethysmography: a noninvasive method for assessment of lung mechanical function in small animals J Appl Physiol, January 1, 2008; 104(1): 253 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agrawal and A. Ram Commentary on "Restrained whole body plethysmography for measure of strain-specific and allergen-induced airway responsiveness in conscious mice" J Appl Physiol, June 1, 2007; 102(6): 2411 - 2411. [Full Text] [PDF] |
||||
![]() |
A. M. Hoffman Reply to Agrawal and Ram J Appl Physiol, June 1, 2007; 102(6): 2412 - 2413. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |